ArticleThe Journal of clinical investigation2017

A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.

Aaron Y Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.